Date : 19 June 2026

| Ecosystem Category | Key Participants | Role in Market |
| Technology Providers | IQVIA, Oracle, Merative, SAS Institute | Provide data integration, analytics, AI, cloud infrastructure, and evidence-generation platforms |
| Product Manufacturers | Flatiron Health, Aetion, TriNetX | Develop RWE software, disease-specific datasets, and analytics products |
| Service Providers | Syneos Health, Parexel, ICON plc | Deliver RWE study design, execution, regulatory support, and consulting |
| Platform Providers | IQVIA, Optum, Oracle, Merative, Flatiron Health | Operate large-scale RWD platforms and evidence-generation environments |
| CROs/CDMOs | ICON plc, Parexel, Syneos Health, Medpace, Thermo Fisher Scientific (PPD) | Conduct RWE studies and integrate evidence into development programs |
| Software Vendors | SAS Institute, Oracle, Cognizant, NTT DATA | Provide analytics, AI, interoperability, and healthcare data management software |
| Research Institutions | FDA Sentinel collaborators, Harvard Medical School, Mayo Clinic, Johns Hopkins University, Duke Clinical Research Institute | Advance RWE methodologies and validation frameworks |
| End-User Industries | Pharma, Biotechnology, Medical Devices, Diagnostics, Payers, Providers | Utilize RWE for development, reimbursement, safety, and commercialization decisions |
R&D:
Manufacturing Processes:
Patient Services:
| Tier 1 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| IQVIA | Durham, North Carolina | USA | Widest healthcare data assets and largest dedicated RWE organization globally | IQVIA RWE Solutions, E360 Platform, HEOR, regulatory evidence generation |
| Optum | Eden Prairie, Minnesota | USA | One of the largest claims and payer data owners in North America | Optum Life Sciences, claims analytics, outcomes research |
| Oracle | Austin, Texas | USA | Major healthcare data and analytics infrastructure provider | Oracle Health, healthcare data platforms, evidence analytics |
| Merative | Ann Arbor, Michigan | USA | Strong RWD analytics and healthcare intelligence capabilities | MarketScan, Micromedex, evidence analytics |
| Flatiron Health | New York, New York | USA | Dominant oncology-focused RWE provider with deep EHR-derived datasets | Flatiron Real-World Data, oncology evidence platforms |
| Tier 2 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| ICON plc | Dublin | Ireland | Leading CRO with significant RWE and HEOR operations in North America | RWE studies, HEOR, regulatory evidence services |
| Parexel | Durham, North Carolina | USA | Major evidence-generation and market access provider | Real-world studies, observational research |
| Syneos Health | Morrisville, North Carolina | USA | Strong integrated clinical and commercial evidence capabilities | RWE consulting, post-market evidence, HEOR |
| Thermo Fisher Scientific (PPD) | Waltham, Massachusetts | USA | Extensive RWE services integrated with clinical development | PPD RWE, epidemiology, outcomes research |
| Medpace | Cincinnati, Ohio | USA | Growing CRO with dedicated observational and RWE programs | Non-interventional studies, registry studies |
| Tier 3 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| Aetion | New York, New York | USA | Industry-leading causal inference and regulatory-grade RWE platform | Aetion Evidence Platform |
| TriNetX | Cambridge, Massachusetts | USA | Large federated clinical research network | Clinical data network, feasibility and RWE analytics |
| HealthVerity | Philadelphia, Pennsylvania | USA | Specialized patient identity resolution and linked RWD assets | Data linkage and evidence-generation solutions |
| OM1 | Boston, Massachusetts | USA | AI-driven real-world outcomes and disease intelligence platform | OM1 Real-World Data Cloud |
| ConcertAI | Cambridge, Massachusetts | USA | Rapidly growing oncology and precision medicine RWE provider | CancerLinQ-linked datasets, AI-enabled evidence generation |
The North America real world evidence solutions market size stood at US$ 1.98 billion in 2025, grew to US$ 2.25 billion in 2026, and is forecast to reach US$ 7.21 billion by 2035, expanding at a CAGR of 13.8% from 2026 to 2035.

Speak with a healthcare analyst about your research, consulting, or platform needs.